What the test actually measures
The biological effects of vitamin D are carried out primarily by 1,25(OH)₂D, also known as calcitriol. This form binds to the vitamin D receptor and changes gene activity. But the standard blood test measures 25(OH)D instead—a more stable circulating metabolite from which the active form is later produced. The lab test was chosen because it was more convenient to measure, not because it perfectly reflects biology.
Even that test is not as simple as it looks on a lab report. Two main forms circulate in the blood: 25(OH)D₂ and 25(OH)D₃. The standard result is usually their sum. Almost all 25(OH)D is bound to vitamin D–binding protein and albumin, with only a small free fraction. So the laboratory is not directly measuring “available vitamin D” but rather a combined concentration of several bound and free fractions of two different forms of the same metabolite.
Low 25(OH)D does not equal low active vitamin D
Here is a key physiological paradox. A drop in 25(OH)D does not automatically mean a drop in active 1,25(OH)₂D. As precursor stores decline, parathyroid hormone can increase its conversion into calcitriol. The active form can therefore remain normal for a long time and sometimes even rise. In other words, low 25(OH)D and a true deficiency of the active hormone are not the same condition.
Local activation: what a blood test rarely sees
There is another important detail. Active vitamin D is not only made in the kidneys and then distributed through the blood. Many tissues can convert 25(OH)D into active 1,25(OH)₂D locally, for their own needs. This includes bone tissue: osteoblasts, osteocytes, and cells of the osteoclast lineage have the necessary enzyme and vitamin D receptors. So 25(OH)D serves not only as a precursor for the circulating hormone but also as raw material for local production inside tissues.
The amount of locally produced calcitriol is barely reflected in a standard blood test. In human bone marrow cells, it has been shown that they can convert 25(OH)D into 1,25(OH)₂D and thereby influence osteoblast maturation. Moreover, different stages of the same bone cell respond differently to vitamin D. In osteoblasts, the effect depends on whether the cell is proliferating, maturing, or already mineralizing matrix. The same hormone switches on different sets of genes in different cell states. So the outcome depends both on the amount of 25(OH)D in the blood and on which cells are using it at a given moment and in what state they are.
How did one concentration become a universal “normal” range?
This raises the main question: how did a single blood concentration of 25(OH)D ever become a universal number for “normal”? The first attempts to set a threshold were far more modest than today’s. In 1991, the United Kingdom set the lower limit at 8 ng/mL. The basis was a 1976 study of just nine children with rickets, whose 25(OH)D levels were roughly between 8 and 20 ng/mL. A few years later, the UK threshold was raised to 10 ng/mL. A review of the history of these recommendations explicitly notes that the exact justification for this increase is unclear and that even something as prosaic as the convenience of a round number for doctors may have played a role.
In 1997, the U.S. Institute of Medicine considered about 11 ng/mL sufficient for children and 12 ng/mL for adults. These were levels below which clear deficiency with risk of rickets and osteomalacia was expected. Even then, the authors acknowledged that the normal range for 25(OH)D was poorly defined and that additional research was needed to assess requirements.
The measurement problem
There was also a separate problem with measuring 25(OH)D itself. Over the years, laboratories used competitive protein-binding assays, radioimmunoassays, automated immunoassays, liquid chromatography, and later mass spectrometry. These methods extracted 25(OH)D from binding proteins differently, recognized D₂ and D₃ forms differently, and had their own systematic biases. The same blood sample could therefore yield noticeably different values depending on the method.
The variation became so large that an international external quality control program, DEQAS, had to be created in 1989. Full international standardization of vitamin D measurements only began in 2010. After old data were re-standardized, it turned out that even part of the supposed decline in vitamin D levels in the U.S. population was due to changes in laboratory methods, not a real change in people’s health.
What modern recommendations say
By 2011, the Institute of Medicine, after reviewing the data, concluded that a 25(OH)D level of about 20 ng/mL covers the needs of roughly 97.5% of healthy people, and that values above 30 ng/mL do not provide consistently confirmed additional benefit for bones. The committee specifically warned that the prevalence of “vitamin D insufficiency” in North America was probably overestimated because of overly high thresholds.
At the same time, the higher threshold of around 30 ng/mL had already become entrenched based on studies of parathyroid hormone, calcium absorption, and observational associations. Even the recommendations that supported it admitted that trials with clinically meaningful outcomes were needed to define such a threshold confidently. In other words, the evidence base remained incomplete.
Inertia has been very long-lasting. Even today, major laboratory networks use different lower limits for the same 25(OH)D test. Mayo Clinic considers 20-50 ng/mL optimal, Labcorp currently lists 20-100 ng/mL, and Quest still uses 30–100 ng/mL and labels 21–29 ng/mL as “insufficiency.” So the same result - say, 25 ng/mL - can be normal at one major American laboratory and “insufficient” at another.
What this means in practice
25(OH)D is a useful marker, but it is not absolute truth. A low number does not always equal a deficiency of the active hormone or a real problem with bones and muscles. Conversely, a “normal” number does not guarantee that local vitamin D activation in tissues is working perfectly. For those who train, this is especially important. Bones and muscles are not passive consumers of vitamin D; they are active participants in its metabolism. But chasing “ideal 30+” based on a single test without context may be unjustified. If you do test 25(OH)D, look beyond the number at your symptoms and overall condition, at other markers such as calcium, parathyroid hormone, phosphate, and alkaline phosphatase, and at factors like season, latitude, lifestyle, diet, and supplements. Also consider the measurement method and the reference range of the specific laboratory. Most importantly, discuss the results with a doctor rather than self-prescribing high doses based on one line on a lab report. The goal is not a perfect number but healthy bones, muscles, and a healthy body overall.
Comments
Post a Comment